Previous close | 190.60 |
Open | 190.60 |
Bid | 184.00 |
Ask | 193.10 |
Strike | 980.00 |
Expiry date | 2026-12-18 |
Day's range | 190.60 - 190.60 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?